SOD1 and breast cancer: The proposition for a novel BC biomarker is the 50 bp insertion/deletion polymorphism in superoxide dismutase (SOD1), where the SOD1 50-bp Ins/Del genotype, as well as Del, allele, was positively correlated with an elevated risk for BC in the Iranian population (Sarabandi et al. 2022).